Pascale Salameh

Prof. Pascale Salameh

National Institute of Public Health, Clinical Epidemiology, and Toxicology-Lebanon (INSPECT-LB), Beirut, Beyrouth, Lebanon
+1
orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2021 in Antimicrobial Resistance & Infection Control
Verified
Journal Article
Open access
PDF file
Katia ISKANDARKatia ISKANDAR
Katia ISKANDAR
LMLaurent Molinier
Laurent Molinier
SHSouheil Hallit
Souheil Hallit
MSMassimo Sartelli
Massimo Sartelli
THTimothy Craig Hardcastle
Timothy Craig Hardcastle
CRChristine Roques
Christine Roques
Data on comprehensive population-based surveillance of antimicrobial resistance is lacking. In low- and middle-income countries, the challenges are high due to weak laboratory capacity, poor health systems governance, lack of health information systems, and limited resources. Developing countries struggle with political and social dilemma, and bear a high health and economic burden of communicable diseases. Available data are fragmented and lack representativeness which limits their use to advice health policy makers and orientate the efficient allocation of funding and financial resources on programs to mitigate resistance. Low-quality data means soaring rates of antimicrobial resistance and the inability to track and map the spread of resistance, detect early outbreaks, and set national health policy to tackle resistance. Here, we review the barriers and limitations of conducting effective antimicrobial resistance surveillance, and we highlight multiple incremental approaches that may offer opportunities to strengthen population-based surveillance if tailored to the context of each country.

30 January 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
Katia ISKANDARKatia ISKANDAR
Katia ISKANDAR
JMJayaseelan Murugaiyan
Jayaseelan Murugaiyan
DHDalal Hammoudi Halat
Dalal Hammoudi Halat
SHSaid El Hage
Said El Hage
VCVindana Chibabhai
Vindana Chibabhai
MDMaarten Van Dongen
Maarten Van Dongen
The history of antimicrobial resistance (AMR) evolution and the diversity of the environmental resistome indicate that AMR is an ancient natural phenomenon. Acquired resistance is a public health concern influenced by the anthropogenic use of antibiotics, leading to the selection of resistant genes. Data show that AMR is spreading globally at different rates, outpacing all efforts to mitigate this crisis. The search for new antibiotic classes is one of the key strategies in the fight against AMR. Since the 1980s, newly marketed antibiotics were either modifications or improvements of known molecules. The World Health Organization (WHO) describes the current pipeline as bleak, and warns about the scarcity of new leads. A quantitative and qualitative analysis of the pre-clinical and clinical pipeline indicates that few antibiotics may reach the market in a few years, predominantly not those that fit the innovative requirements to tackle the challenging spread of AMR. Diversity and innovation are the mainstays to cope with the rapid evolution of AMR. The discovery and development of antibiotics must address resistance to old and novel antibiotics. Here, we review the history and challenges of antibiotics discovery and describe different innovative new leads mechanisms expected to replenish the pipeline, while maintaining a promising possibility to shift the chase and the race between the spread of AMR, preserving antibiotic effectiveness, and meeting innovative leads requirements.

1 February 2016 in Clinical Nutrition
Verified
Journal Article
Closed access
CBChrista Boulos
Christa Boulos
Pascale SalamehPascale Salameh
Pascale Salameh
PBPascale Barberger-Gateau
Pascale Barberger-Gateau

21 January 2016 in Geriatrics & Gerontology International
Verified
Journal Article
Closed access
PDF file
CBChrista Boulos
Christa Boulos
Pascale SalamehPascale Salameh
Pascale Salameh
PBPascale Barberger‐Gateau
Pascale Barberger‐Gateau

1 July 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
Katia ISKANDARKatia ISKANDAR
Katia ISKANDAR
LMLaurent Molinier
Laurent Molinier
SHSouheil Hallit
Souheil Hallit
Massimo SartelliMassimo Sartelli
Massimo Sartelli
Fausto CatenaFausto Catena
Fausto Catena
Pascale SalamehPascale Salameh
Pascale Salameh
Antibiotic resistance is an ecosystem problem threatening the interrelated human-animal-environment health under the “One Health” framework. Resistant bacteria arising in one geographical area can spread via cross-reservoir transmission to other areas worldwide either by direct exposure or through the food chain and the environment. Drivers of antibiotic resistance are complex and multi-sectoral particularly in Lower- and Middle-income countries. These include inappropriate socio-ecological behaviors; poverty; overcrowding; lack of surveillance systems; food supply chain safety issues; highly contaminated waste effluents; and loose rules and regulations. In order to examine the drivers of antibiotic resistance from a “one health” perspective, a literature review was conducted on three databases including PubMed, Medline and Google Scholar. A total of 485 studies of potential relevance were selected, out of which 182 were included in this review. Results have shown that the aforementioned market failures are the leading cause for the negative externality of antibiotic resistance that extends in scope from the individual to the global ecosystem. Incremental and sustainable global actions can make the change, however, the problem will continue to prevail if governments do not prioritize the “One health” approach and if individual’s accountability is still denied in a world struggling with profound socio-economic problems.

1 January 2008 in Nicotine & Tobacco Research
Verified
Journal Article
Closed access
PDF file
Pascale SalamehPascale Salameh
Pascale Salameh
MWMirna Waked
Mirna Waked
ZBZeina Aoun Bacha
Zeina Aoun Bacha
Waterpipe smoking is becoming fashionable in Lebanon, but no studies have studied nicotine dependence related to waterpipe smoking. A score was constructed from 21 items and subsequently submitted to two factor analyses, which led to the extraction of four factors. Reliability and test–retest reproducibility were measured. Convergent construct validity and discriminant validity also were assessed for different smokers' samples. The Lebanon Waterpipe Dependence Scale-11 (LWDS-11) was composed of four subscales, the first representing nicotine dependence, the second negative reinforcement, the third psychological craving, and the fourth positive reinforcement. Internal consistency and test–retest reproducibility were adequate, and the subscales correlated adequately with measurements of nicotine metabolites, exhaled carbon monoxide levels, and the frequency of waterpipe smoking. The LWDS-11 discriminated between mild, moderate, and heavy waterpipe smokers, based on a threshold score of 10. Results were biologically and psychologically sound. This is the first scale to characterize waterpipe dependence. With further improvement and confirmation, it could become a useful clinical and epidemiological tool.